Skip to content

A Post-Market Retrospective Study on Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis

A Post-Market, Single-Center, Retrospective Study to Collect Clinical Outcomes and Safety Data From Patients Who Have Undergone Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis and Are at Least 2 Years Past Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02912351
Enrollment
24
Registered
2016-09-23
Start date
2017-01-31
Completion date
2022-03-31
Last updated
2022-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Keywords

Total Knee Arthroplasty, Total Knee Replacement, Revision Knee Arthroplasty

Brief summary

This is a retrospective, single-site observational study, designed to assess the clinical outcomes and collect safety data of GMK Revision knee system used for primary or revision total knee arthroplasty at minimum two years post-treatment.

Interventions

OTHERPatient record review, Radiographs, and questionaires.

KSS-Objective Knee Scores, KSS Subsets, Radiographs and Patient Satisfaction

Sponsors

Medacta USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to any study procedure. * Patients with ability to understand and provide written authorization for use and disclosure of personal health information * Patients must be willing to comply with the post-operative evaluation schedule. * Patients underwent either a primary or revision total knee replacement for any type of etiology (Osteoarthritis, Avascular necrosis, Rheumatoid Arthritis, Post-traumatic Arthritis, Polyarthritis, Primary implantation failure). * Patients must have received a GMK Revision component * Patients must be at minimum 2 year (24 months) post-treatment * The operation was performed or supervised by the investigator. * No age limit criteria

Exclusion criteria

* History of alcoholism * Currently on chemotherapy or radiation therapy * Habitual use of narcotic pain medications prior to surgery or after surgery for reasons other than knee pain * History of a metabolic disorder affecting the skeletal system other than osteoarthritis or osteoporosis * History of chronic pain issues for reasons other than knee pain * Women that are pregnant

Design outcomes

Primary

MeasureTime frameDescription
Total Knee Society Scores (KSS)Minimum 2 years post surgeryTotal Knee Society Score questionnaire to assess Patient satisfaction and Patient expectations and objective knee scores.

Secondary

MeasureTime frameDescription
Radiographic AnalysisMinimum 2 years post surgeryRadiographic analysis will include evaluation of component and limb alignment, evidence of component subsidence or migration and the presence and progression of radiolucent line between the prosthesis, bone and cement.
Patient SatisfactionMinimum 2 years post surgeryAssessed with a Likert scale questionnaire for satisfaction of treatment outcome.
Complication Assessmentminimum 2 years post surgeryby reviewing Adverse Events

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026